154 related articles for article (PubMed ID: 17478924)
1. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
Yang JB; McCarthy JB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
[TBL] [Abstract][Full Text] [Related]
2. The tandem PDZ domains of syntenin promote cell invasion.
Meerschaert K; Bruyneel E; De Wever O; Vanloo B; Boucherie C; Bracke M; Vandekerckhove J; Gettemans J
Exp Cell Res; 2007 May; 313(9):1790-804. PubMed ID: 17451681
[TBL] [Abstract][Full Text] [Related]
3. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
[TBL] [Abstract][Full Text] [Related]
4. mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis.
Sarkar D; Boukerche H; Su ZZ; Fisher PB
Cancer Res; 2008 May; 68(9):3087-93. PubMed ID: 18451132
[TBL] [Abstract][Full Text] [Related]
5. The ins and outs of syntenin, a multifunctional intracellular adaptor protein.
Beekman JM; Coffer PJ
J Cell Sci; 2008 May; 121(Pt 9):1349-55. PubMed ID: 18434645
[TBL] [Abstract][Full Text] [Related]
6. Melanoma metastasis is associated with enhanced expression of the syntenin gene.
Helmke BM; Polychronidis M; Benner A; Thome M; Arribas J; Deichmann M
Oncol Rep; 2004 Aug; 12(2):221-8. PubMed ID: 15254681
[TBL] [Abstract][Full Text] [Related]
7. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
[TBL] [Abstract][Full Text] [Related]
8. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
[TBL] [Abstract][Full Text] [Related]
9. PDZ domain-phosphoinositide interactions in cell-signaling.
Zimmermann P
Verh K Acad Geneeskd Belg; 2006; 68(4):271-86. PubMed ID: 17214441
[TBL] [Abstract][Full Text] [Related]
10. Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions.
Shimada T; Yasuda S; Sugiura H; Yamagata K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454940
[TBL] [Abstract][Full Text] [Related]
11. The tandem PDZ protein Syntenin interacts with the aminoacyl tRNA synthetase complex in a lysyl-tRNA synthetase-dependent manner.
Meerschaert K; Remue E; De Ganck A; Staes A; Boucherie C; Gevaert K; Vandekerckhove J; Kleiman L; Gettemans J
J Proteome Res; 2008 Nov; 7(11):4962-73. PubMed ID: 18839981
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
13. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
[TBL] [Abstract][Full Text] [Related]
14. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling.
Chen F; Du Y; Zhang Z; Chen G; Zhang M; Shu HB; Zhai Z; Chen D
Cell Signal; 2008 Apr; 20(4):666-74. PubMed ID: 18234474
[TBL] [Abstract][Full Text] [Related]
15. Nuclear speckles and nucleoli targeting by PIP2-PDZ domain interactions.
Mortier E; Wuytens G; Leenaerts I; Hannes F; Heung MY; Degeest G; David G; Zimmermann P
EMBO J; 2005 Jul; 24(14):2556-65. PubMed ID: 15961997
[TBL] [Abstract][Full Text] [Related]
16. mda-9/Syntenin: a positive regulator of melanoma metastasis.
Boukerche H; Su ZZ; Emdad L; Baril P; Balme B; Thomas L; Randolph A; Valerie K; Sarkar D; Fisher PB
Cancer Res; 2005 Dec; 65(23):10901-11. PubMed ID: 16322237
[TBL] [Abstract][Full Text] [Related]
17. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
[TBL] [Abstract][Full Text] [Related]
18. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
[TBL] [Abstract][Full Text] [Related]
19. Syntenin-targeted peptide blocker inhibits progression of cancer cells.
Liu J; Qu J; Zhou W; Huang Y; Jia L; Huang X; Qian Z; Xia J; Yu Y
Eur J Med Chem; 2018 Jun; 154():354-366. PubMed ID: 29857221
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induces the PDZ domain-containing syntenin in the marine teleost Paralichthys olivaceus.
Kong HJ; Kim JM; Moon JH; Kim YO; Nam BH; Kim WJ; Lee JH; Lee SJ; Kim KK; Yeo SY; Lee CH
Comp Biochem Physiol C Toxicol Pharmacol; 2010 Aug; 152(2):195-201. PubMed ID: 20382261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]